Jump to content
IndiaDivine.org

PETA demands explanation on Lilly’s animal outsourcing shift

Rate this topic


Guest guest

Recommended Posts

PETA demands explanation on Lilly’s animal outsourcing shift

By Staff Reporter

DrugResearcher.com

 

17/11/2006 - Pharmaceutical company Eli Lilly, has been asked to justify its

decision to outsource its animal testing to countries with no or poor animal

welfare standards, which go against Lilly’s commitment to reducing, refining,

and replacing its use of animals.

 

The call by animal welfare group People for the Ethical Treatment of Animals

(PETA) is another potential embarrassment for Lilly, who are still reeling from

an investigation exposing the conduct of a contract research organisation (CRO)

the drug maker regularly used.

 

The group is concerned that Lilly may be trying to avoid US animal welfare laws

by selecting countries with less stringent rules as well as a more relaxed

attitude to animal testing.

 

A recent article in Forbes magazine discussed Lilly's outsourcing to China,

where, " scientists are cheap, lab animals plentiful, and pesky protesters held

at bay. "

 

The article also cited a pharmaceutical industry executive who " admits that

Chinese testing companies lack quality control and high standards on treatment. "

 

Relocating research to a region with non-existent or weak animal welfare

standards is in direct conflict with Lilly's stated commitment to reducing,

refining, and replacing its use of animals.

 

Eli Lilly's Animal Care and Use Policy states that: “We are dedicated to the

discovery and development of highest quality products that improve the health

and well-being of people and animals around the world.

 

“We are committed to the careful and thorough evaluation of our products using

the best scientific technologies available. Meeting this commitment requires the

use of animals. We recognise that, in doing so, we have an ethical and

scientific obligation to ensure the appropriate treatment of animals used in

research, to minimise the number of animals involved, and to pursue the

development of alternative test systems.â€

 

Following an undercover investigation of Covance—a contract laboratory used by

Lilly, this commitment seems to ring hollow as the investigation revealed that

workers were seen striking and choking monkeys who did not receive any medical

attention for severe injuries.

 

In response, PETA submitted a resolution calling on Lilly to hold its contract

laboratories to the standards outlined in the company's animal welfare policy.

 

The measure received enough votes for PETA to resubmit the same resolution again

this year.

 

" If Lilly was oblivious to the rampant abuse going on at a laboratory that it

uses here in the US, how will the company guarantee that animals aren't being

cruelly treated at laboratories in China? " commented PETA Senior Vice President

Mary Beth Sweetland.

 

" Shareholders deserve an explanation for this move and a guarantee that research

will be held to US standards, at the very least. "

 

Eli Lilly has recently announced plans to set up research units in China as it

looks towards taking a slice of the booming outsourcing industry in the East.

Currently, the global market for animal testing, which was worth $3bn last year,

could double by 2008.

 

http://www.drugresearcher.com/news/ng.asp?n=72089-eli-lilly-peta-animal-testing

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...